NCT03737175 (ESCALATE) is a NA clinical trial of Carotid Artery Stenting in Carotid Stenosis, sponsored by Xuanwu Hospital, Beijing.

Who is sponsoring NCT03737175?

NCT03737175 is sponsored by Xuanwu Hospital, Beijing.

What drugs are being tested in NCT03737175?

Interventions in NCT03737175: Carotid Artery Stenting, Carotid Endarterectomy.

What condition does NCT03737175 study?

NCT03737175 studies Carotid Stenosis.

Is NCT03737175 still recruiting?

NCT03737175 is currently status unknown. Last updated 9 November 2018.

Last reviewed 2018-11-09 · How we verify

NCT03737175: ESCALATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients

Status unknown NA Last updated 9 November 2018

What this trial tests

NA trial testing Carotid Artery Stenting in Carotid Stenosis in 600 participants. Status unknown.

Timeline

30 March 2018

Primary endpoint
1 May 2019

1 April 2021

Quick facts

Lead sponsor	Xuanwu Hospital, Beijing
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	600
Start date	30 March 2018
Primary completion	1 May 2019
Estimated completion	1 April 2021
Sites	6 locations across China

Drugs / interventions tested

Carotid Artery Stenting
Carotid Endarterectomy

Conditions studied

Carotid Stenosis — all drugs for Carotid Stenosis →

Sponsor

Xuanwu Hospital, Beijing

Who can join

50 and older, any sex, with Carotid Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endarterectomy vs Stenting Asymptomatic Carotid stenosis patients to verify the efficacy and safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Carotid Artery Stenting

Trials testing the same drug.

NCT05093127 — CArotid Robotic Procedure Evaluation · completed
NCT03764306 — New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis · NA · terminated

Other recruiting trials for Carotid Stenosis

Currently open trials in the same condition.

NCT07412249 — Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis · NA · recruiting
NCT07057297 — Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study · recruiting
NCT06546761 — Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial) · recruiting
NCT06986330 — Endovascular Treatment of Cerebrovascular Diseases Guided by Optical Coherence Tomography (OCT) Technology（CVD-OCT） · active not recruiting
NCT06485102 — Differences of the Postoperative Outcome for Carotid Surgery Patients Treated by Either Male or Female Surgeons · active not recruiting

Other Xuanwu Hospital, Beijing trials

Trials by the same sponsor.

NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
NCT07519044 — Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion · Phase 4 · not yet recruiting
NCT07396077 — Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II · NA · not yet recruiting
NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease · Phase 1, PHASE2 · not yet recruiting
NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03737175 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xuanwu Hospital, Beijing
Last refreshed: 9 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03737175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing